<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR18">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Slostad</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: a single patient experience</article-title>
  <source>Am. J. Hematol.</source>
  <year>2018</year>
  <volume>93</volume>
  <fpage>E47</fpage>
  <lpage>E49</lpage>
  <pub-id pub-id-type="doi">10.1002/ajh.24971</pub-id>
  <?supplied-pmid 29134683?>
  <pub-id pub-id-type="pmid">29134683</pub-id>
 </element-citation>
</ref>
